These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23395976)

  • 21. Production and single-step purification of EGFP and a biotinylated version of the Human Rhinovirus 14 3C protease.
    Youell J; Fordham D; Firman K
    Protein Expr Purif; 2011 Oct; 79(2):258-62. PubMed ID: 21605680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific and efficient cleavage of fusion proteins by recombinant plum pox virus NIa protease.
    Zheng N; Pérez Jde J; Zhang Z; Domínguez E; Garcia JA; Xie Q
    Protein Expr Purif; 2008 Feb; 57(2):153-62. PubMed ID: 18024078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of a Human Rhinovirus-14 3C Protease-Inducible Caspase-3.
    Wagner HJ; Weber W
    Molecules; 2019 May; 24(10):. PubMed ID: 31117169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineering a novel endopeptidase based on SARS 3CL(pro).
    Kuo CJ; Shih YP; Kan D; Liang PH
    Biotechniques; 2009 Dec; 47(6):1029-32. PubMed ID: 20041855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetic analysis of the conjugation of ubiquitin to picornavirus 3C proteases catalyzed by the mammalian ubiquitin-protein ligase E3alpha.
    Lawson TG; Sweep ME; Schlax PE; Bohnsack RN; Haas AL
    J Biol Chem; 2001 Oct; 276(43):39629-37. PubMed ID: 11526102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new tagged-TEV protease: construction, optimisation of production, purification and test activity.
    Miladi B; Bouallagui H; Dridi C; El Marjou A; Boeuf G; Di Martino P; Dufour F; Elm'Selmi A
    Protein Expr Purif; 2011 Jan; 75(1):75-82. PubMed ID: 20817099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Covalent immobilization of tobacco-etch-virus NIa protease: a useful tool for cleavage of the histidine tag of recombinant proteins.
    Puhl AC; Giacomini C; Irazoqui G; Batista-Viera F; Villarino A; Terenzi H
    Biotechnol Appl Biochem; 2009 May; 53(Pt 3):165-74. PubMed ID: 18937642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biologically active protease 3C of human rhinovirus 1A is expressed from a cloned cDNA segment in Escherichia coli.
    Aschauer B; Werner G; McCray J; Rosenwirth B; Bachmayer H
    Virology; 1991 Oct; 184(2):587-94. PubMed ID: 1653490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rhinovirus 3C protease catalyzes efficient cleavage of a fluorescein-labeled peptide affording a rapid and robust assay.
    Hopkins JL; Betageri R; Cohen KA; Emmanuel MJ; Joseph CR; Bax PM; Pallai PV; Skoog MT
    J Biochem Biophys Methods; 1991 Sep; 23(2):107-13. PubMed ID: 1658106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substrate requirements of human rhinovirus 3C protease for peptide cleavage in vitro.
    Cordingley MG; Callahan PL; Sardana VV; Garsky VM; Colonno RJ
    J Biol Chem; 1990 Jun; 265(16):9062-5. PubMed ID: 2160953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The P1' specificity of tobacco etch virus protease.
    Kapust RB; Tözsér J; Copeland TD; Waugh DS
    Biochem Biophys Res Commun; 2002 Jun; 294(5):949-55. PubMed ID: 12074568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TEV protease cleavage in generation of artificial substrate proteins bearing neo-N-termini.
    Winckler LI; Dissmeyer N
    Methods Enzymol; 2023; 686():125-141. PubMed ID: 37532397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-covalent inhibitors of rhinovirus 3C protease.
    Baxter A; Chambers M; Edfeldt F; Edman K; Freeman A; Johansson C; King S; Morley A; Petersen J; Rawlins P; Spadola L; Thong B; Van de Poël H; Williams N
    Bioorg Med Chem Lett; 2011 Jan; 21(2):777-80. PubMed ID: 21183345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P1' specificity of the S219V/R203G mutant tobacco etch virus protease.
    Golda M; Hoffka G; Cherry S; Tropea JE; Lountos GT; Waugh DS; Wlodawer A; Tőzsér J; Mótyán JA
    Proteins; 2024 Sep; 92(9):1085-1096. PubMed ID: 38666764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NMR solution structures of the apo and peptide-inhibited human rhinovirus 3C protease (Serotype 14): structural and dynamic comparison.
    Bjorndahl TC; Andrew LC; Semenchenko V; Wishart DS
    Biochemistry; 2007 Nov; 46(45):12945-58. PubMed ID: 17944485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel self-cleavage system for production of soluble recombinant protein in Escherichia coli.
    Feng Y; Xu Q; Yang T; Sun E; Li J; Shi D; Wu D
    Protein Expr Purif; 2014 Jul; 99():64-9. PubMed ID: 24727155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficient and rapid affinity purification of proteins using recombinant fusion proteases.
    Walker PA; Leong LE; Ng PW; Tan SH; Waller S; Murphy D; Porter AG
    Biotechnology (N Y); 1994 Jun; 12(6):601-5. PubMed ID: 7764949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A simple solid phase, peptide-based fluorescent assay for the efficient and universal screening of HRV 3C protease inhibitors.
    Schünemann K; Connelly S; Kowalczyk R; Sperry J; Wilson IA; Fraser JD; Brimble MA
    Bioorg Med Chem Lett; 2012 Aug; 22(15):5018-24. PubMed ID: 22763202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Site-directed mutagenesis suggests close functional relationship between a human rhinovirus 3C cysteine protease and cellular trypsin-like serine proteases.
    Cheah KC; Leong LE; Porter AG
    J Biol Chem; 1990 May; 265(13):7180-7. PubMed ID: 2158990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of recombinant fusion proteases in the affinity purification of recombinant proteins.
    Leong LE
    Mol Biotechnol; 1999 Oct; 12(3):269-74. PubMed ID: 10631683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.